1. sayfa ve
Tekrarlanan kayıtlar tek bir kaynakta birleştirilmektedir.
1
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Are children less susceptible to COVID-19?
2
e-Kitap

e-Kitap

Kaynak
:
Yazar(lar) :
Yıl :
2020
COVID-19 PCR Testing Update From Missouri DHSS COVID-
19 PCR Testing Update From Missouri DHSS; coronavirus; testing criteria; symptoms; communicable diseases; health care; clinicians; epidemiology;
3
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Myasthenic crisis in COVID-19 COVID-19
4
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Liver Injury in COVID-19: Caution and Management
5
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Neurological manifestations in COVID-19: A narrative review COVID-
19, a respiratory viral infection, has affected more than 10 million individuals worldwide. We have outlined the common neurological manifestations in
COVID-
19 (information are up-to-date as of June 2020) and discussed the possible pathogenetic
6
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19: the novel SARS-CoV-2 pandemic
7
Dergi Makalesi

Dergi Makalesi

Kaynak
:
Yayıncı:
ORA - Oxford University Research Archive
Yıl :
2020
Monitoring respiratory infections in covid-19 epidemics
8
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning
9
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Syncope, Brugada syndrome, and COVID‐19 lung disease COVID‐19 lung disease
10
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Features of anosmia in COVID-19 Background Medical publications about anosmia with
COVID-
19 are scarce. We aimed to describe the prevalence and features of anosmia in
COVID-
19 patients. Results Fifty-four of 114 patients (47%) with confirmed
COVID-
19 reported anosmia. COVID-19
11
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Current regulatory approaches for accessing potential COVID-19 therapies Abstract This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating
COVID-
19 potential therapies either COVID-19
12
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Low-Dose Radiotherapy for Late-Stage COVID-19 Pneumonia? The unimaginable daily death toll of thousands of victims dying from
COVID-
19 pneumonia and the marginal therapeutic value of agents tested, brings forward the re-evaluation of the position of radiotherapy in the treatment of late stage lethal
COVID-induced respiratory failure. Whether radiotherapy, in conjunction with remdesivir and/or macrolides can reduce the dramatic death rates related to
COVID-
19 is an open challenge, under
13
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Safety of an immunomodulator Mycobacterium w in COVID-19
14
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Jun Wang
,
Jun Wang
,
Jun Wang
,
Qian Li
,
Qian Li
,
Yongmei Yin
,
Yingying Zhang
,
Yingying Cao
,
Xiaoming Lin
,
Lihua Huang
,
Lihua Huang
,
Daniel Hoffmann
,
Mengji Lu
,
Yuanwang Qiu
,
Yuanwang Qiu
,
Yuanwang Qiu
Yıl :
2020
Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19 Background: Cases of excessive neutrophil counts in the blood in severe coronavirus disease (
COVID-
19) patients have drawn significant attention. It is urgent to clarify the pathogenesis of neutrophils leading to severe pneumonia in
COVID-
19.Methods: A retrospective analysis was performed on 55
COVID Transcriptome analysis revealed that neutrophil activation was correlated with 17 neutrophil extracellular trap (NET)-associated genes in
COVID-
19 patients COVID-19
15
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
COVID-19-associated delayed posthypoxic necrotizing leukoencephalopathy
16
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Thromboinflammation in COVID-19 acute lung injury COVID-
19 also presents with a severe coagulopathy with a high rate of venous thromboembiolism. In our experience as a
COVID-
19 epicenter, children and young adults do develop both the coagulopathy and the ALI of
COVID-
19. This review will discuss
COVID-
19 ALI from a hematological perspective with discussion of the distinct aspects of coagulation that are apparent in
COVID COVID-19
17
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
COVID-19 and Cerebral Hemorrhage: Proposed Mechanisms
18
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Hemorrhagic stroke and anticoagulation in COVID-19 Background and Purpose Patients with the Coronavirus Disease of 2019 (
COVID-
19) are at increased risk for thrombotic events and mortality. Methods Patients over the age of 18 with confirmed
COVID-
19 and radiographic evidence of ICH were included in this study. Results We identified 33
COVID-
19 positive patients with ICH, mean age 61.6 years (range 37–83 years), 21.2% of whom were female. COVID-19
19
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Rethinking high-risk groups in COVID-19 COVID-19
20
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Spectrum of neuropsychiatric manifestations in COVID-19 Corona Virus Disease 2019 (
COVID-
19) emerged in December 2019 from Wuhan, China. We analyzed
COVID-
19 adult patients in the TriNetX database, which is a global health collaborative clinical research platform collecting real-time electronic -
19 among whom 9086 (22.5%) patients had neuropsychiatric manifestations.
21
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
A cautionary tale of false-negative nasopharyngeal COVID-19 testing Serial testing for
COVID-
19 is indicated in patients with high pretest probability of disease. COVID-19
22
Dergi Makalesi

Dergi Makalesi

Kaynak
:
Yayıncı:
ORA - Oxford University Research Archive
Yazar(lar) :
Ellul M
,
Varatharaj A
,
Nicholson T
,
Pollack T
,
Zandi MS
,
Manji H
,
Solomon T
,
Carson A
,
Turner MR
,
Kneen R
,
Galea I
,
Pett S
,
Thomas RH
,
Michael BD
Yıl :
2020
Defining causality in COVID-19 and neurological disorders
23
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Neurologic Involvement in COVID-19: Radiologists’ Perspective
24
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Nebulized Lidocaine in COVID-19, An Hypothesis Coronavirus Diseases-2019 (
COVID-
19) has caused a large global outbreak and has been declared as a pandemic by the World Health Organization (WHO). It has been proposed that
COVID-
19-related hyperinflammation and dysregulated immune response might play a critical role in developing a cytokine storm It is proposed that nebulized lidocaine might be beneficial in reducing cytokines, protecting patients’ lungs and improving outcomes in
COVID-
19 patients COVID-19
25
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Ozone Therapy as a Possible Option in COVID-19 Management COVID-19
26
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
EEG findings in COVID-19 related encephalopathy
27
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Ivermectin in COVID-19. Argumentun ad ignorantiam?
28
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yazar(lar) :
Konu :
Pharmacology
Yıl :
2020
Sex‐related differences in COVID‐19 lethality Many countries have been affected by the worldwide outbreak of
COVID‐
19. In Italy and elsewhere, women seem to be less affected than men by severe/fatal
COVID‐
19 infection, regardless of their age.
29
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
East meets West in COVID-19 therapeutics